ID   UROtsa Cd#1-SPARC
AC   CVCL_LM65
SY   Cd#1-SPARC
DR   Wikidata; Q54991828
RX   PubMed=26783756;
CC   Transfected with: HGNC; 11219; SPARC.
CC   Transformant: ChEBI; CHEBI:48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IX03 ! UROtsa Cd#1
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=26783756; DOI=10.1371/journal.pone.0147362;
RA   Slusser-Nore A., Larson-Casey J.L., Zhang R.-W., Zhou X.-D., Somji S.,
RA   Garrett S.H., Sens D.A., Dunlevy J.R.;
RT   "SPARC expression is selectively suppressed in tumor initiating
RT   urospheres isolated from As+3- and Cd+2-transformed human urothelial
RT   cells (UROtsa) stably transfected with SPARC.";
RL   PLoS ONE 11:E0147362-E0147362(2016).
//